Peter Peduzzi

Follow

Generating author description...

All published works
Action Title Year Authors
+ Endpoint assessment via routinely collected data generates estimates comparable to randomized controlled trial data: analysis of a cluster-randomized trial on fall injury prevention 2025 David A. Ganz
Erich J. Greene
Nancy K. Latham
Michael J. Kane
Lillian Min
Thomas M. Gill
David B. Reuben
Peter Peduzzi
Denise Esserman
+ Statistical Methods for Accommodating Immortal Time: A Selective Review and Comparison 2024 Jiping Wang
Peter Peduzzi
Michael Wininger
Shuangge Ma
+ Unresolved issues with noninferiority pragmatic trials: Results of a literature survey 2023 Maria Ciarleglio
Jiaxuan Li
Peter Peduzzi
+ Simulating time-to-event data subject to competing risks and clustering: A review and synthesis 2022 Can Meng
Denise Esserman
Fan Li
Yize Zhao
Ondƙej Bláha
Wenhan Lu
Yuxuan Wang
Peter Peduzzi
Erich J. Greene
+ PDF Chat Issues with Specification of Margins and Analytic Methods on Potential Bias Towards the Alternative in Randomized Noninferiority Pragmatic Trials: Results of a Literature Survey 2022 Maria Ciarleglio
Jiaxuan Li
Peter Peduzzi
+ A comparison of analytical strategies for cluster randomized trials with survival outcomes in the presence of competing risks 2022 Fan Li
Wenhan Lu
Yuxuan Wang
Zehua Pan
Erich J. Greene
Guanqun Meng
Can Meng
Ondƙej Bláha
Yize Zhao
Peter Peduzzi
+ Sample size calculation in hierarchical 2×2 factorial trials with unequal cluster sizes 2022 Zizhong Tian
Denise Esserman
Guangyu Tong
Ondƙej Bláha
James Dziura
Peter Peduzzi
Fan Li
+ Statistical Methods for Accommodating Immortal Time: A Selective Review and Comparison 2022 Jiping Wang
Peter Peduzzi
Michael Wininger
Shuangge Ma
+ Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial 2021 Guangyu Tong
Karen H. Seal
William C. Becker
Fan Li
James Dziura
Peter Peduzzi
Denise Esserman
+ PDF Chat Estimation of ascertainment bias and its effect on power in clinical trials with time‐to‐event outcomes 2020 Erich J. Greene
Peter Peduzzi
James Dziura
Can Meng
Michael E. Miller
Thomas G. Travison
Denise Esserman
+ Developing New Statistical Methods for Clinical Studies Where Patients Choose Their Treatments 2020 Denise Esserman
Peter Peduzzi
Michael J. Kane
Briana Cameron
Yu Shi
+ Two‐stage randomized trial design for testing treatment, preference, and self‐selection effects for count outcomes 2020 Yu Shi
Briana Cameron
Xian Gu
Michael J. Kane
Peter Peduzzi
Denise Esserman
+ PDF Chat A joint model for recurrent events and a semi-competing risk in the presence of multi-level clustering 2018 Tae Hyun Jung
Peter Peduzzi
Heather Allore
Tassos C. Kyriakides
Denise Esserman
+ Extensions to the two‐stage randomized trial design for testing treatment, self‐selection, and treatment preference effects to binary outcomes 2018 Briana Cameron
Peter Peduzzi
Denise Esserman
+ PDF Chat ANALYSIS OF TRIALS WITH MULTI-LEVEL CLUSTERING, RECURRENT EVENTS AND COMPETING RISKS 2017 Heather Allore
Tae Hyun Jung
Denise Esserman
Peter Peduzzi
+ Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure 2016 Maria Ciarleglio
Christopher D. Arendt
Peter Peduzzi
+ PDF Chat A Longitudinal, Observational Study with Many Repeated Measures Demonstrated Improved Precision of Individual Survival Curves Using Bayesian Joint Modeling of Disability and Survival 2015 Terrence E. Murphy
Heather Allore
Ling Han
Peter Peduzzi
Thomas M. Gill
Xiao Xu
Haiqun Lin
+ Selection of the treatment effect for sample size determination in a superiority clinical trial using a hybrid classical and Bayesian procedure 2015 Maria Ciarleglio
Christopher D. Arendt
Robert Makuch
Peter Peduzzi
+ U.S. Department of Veterans Affairs Cooperative Studies Program 2014 William G. Henderson
Philip W. Lavori
Peter Peduzzi
Joseph F. Collins
Mike R. Sather
John R. Feussner
+ PDF Chat A dynamic trajectory class model for intensive longitudinal categorical outcome 2014 Haiqun Lin
Ling Han
Peter Peduzzi
Terrence E. Murphy
Thomas M. Gill
Heather Allore
+ Strategies for dealing with missing data in clinical trials: from design to analysis. 2013 James Dziura
Lori Ann Post
Qing Zhao
Zhixuan Fu
Peter Peduzzi
+ PDF Chat Treatment of Death in the Analysis of Longitudinal Studies of Gerontological Outcomes 2010 Terrence E. Murphy
Lanlan Han
Heather Allore
Peter Peduzzi
Thomas M. Gill
Haiqun Lin
+ PDF Chat A Semiparametric Transition Model with Latent Traits for Longitudinal Multistate Data 2008 Haiqun Lin
Zhenchao Guo
Peter Peduzzi
Thomas M. Gill
Heather Allore
+ A case study found that a regression tree outperformed multiple linear regression in predicting the relationship between impairments and Social and Productive Activities scores 2005 Heather Allore
Mary E. Tinetti
Katy Araujo
Susan Hardy
Peter Peduzzi
+ Application of negative binomial modeling for discrete outcomes 2003 Amy L. Byers
Heather Allore
Thomas M. Gill
Peter Peduzzi
+ PDF Chat Analysis of Randomized Controlled Trials 2002 Peter Peduzzi
+ Validation of a staging system for evaluating prognosis in prostate cancer. 2000 Daniel R. Anderson
Shreenath Patil
Ayumi Kamina
David F. Penson
Peter Peduzzi
John Concato
+ A simulation study of the number of events per variable in logistic regression analysis 1996 Peter Peduzzi
John Concato
Elizabeth Kemper
Theodore R. Holford
Alvan R. Feinstein
+ Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates 1995 Peter Peduzzi
John Concato
Alvan R. Feinstein
Theodore R. Holford
+ A18 A simulation study of the number of events per variable recommended in multivariable regression analyses 1993 Peter Peduzzi
John Concato
Alvan R. Feinstein
Theodore R. Halford
+ Analysis as‐randomized and the problem of non‐adherence: An example from the veterans affairs randomized trial of coronary artery bypass surgery 1993 Peter Peduzzi
Janet Wittes
Katherine M. Detre
Theodore Holford
+ Termination of the Department of Veterans Affairs Cooperative Study of steroid therapy for systemic sepsis 1991 Peter Peduzzi
+ Intent-to-treat analysis and the problem of crossovers 1991 Peter Peduzzi
Katherine M. Detre
Janet Wittes
Theodore Holford
+ A computer program for calculating ratio estimates 1989 Victor F. Latvis
Peter Peduzzi
+ General statistical design considerations of randomized clinical trials. 1988 Peter Peduzzi
+ Comparison of the logistic and Cox regression models when outcome is determined in all patients after a fixed period of time 1987 Peter Peduzzi
Theodore Holford
Katherine M. Detre
Yick-Kwong Chan
+ Upper and lower bounds for correlations in 2 × 2 tables-revisited 1983 Peter Peduzzi
Katherine M. Detre
Yick-Kwong Chan
+ Management of a multicenter clinical trial 1983 Yick-Kwong Chan
Debbie Archibald
Peter Peduzzi
+ Validation of a risk function to predict mortality in a VA population with coronary artery disease 1982 Peter Peduzzi
Katherine M. Detre
Yick-Kwong Chan
Albert Oberman
Gary Cutter
+ A computer program for transition life tables 1981 Cynthia Ziemba
Dorothea Collins
Peter Peduzzi
Katherine M. Detre
+ A computer program for comparing survival experience of two groups after adjustment for relevant covariates 1980 Dorothea Collins
Peter Peduzzi
Katherine M. Detre
Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ Evaluation of Response-Time Data Involving Transient States: An Illustration Using Heart-Transplant Data 1974 Nathan Mantel
David P. Byar
5
+ The Robust Inference for the Cox Proportional Hazards Model 1989 D. Y. Lin
L. J. Wei
4
+ Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease 1959 Nathan Mantel
William Haenszel
3
+ Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal Distributions 1989 L. J. Wei
D. Y. Lin
Lisa A. Weissfeld
3
+ Longitudinal data analysis using generalized linear models 1986 Kung‐Yee Liang
Scott L. Zeger
3
+ PDF Chat Review of Recent Methodological Developments in Group-Randomized Trials: Part 2—Analysis 2017 Elizabeth L. Turner
MĂ©lanie Prague
John A. Gallis
Fan Li
David M. Murray
3
+ Joint modelling of longitudinal measurements and event time data 2000 Robert Henderson
3
+ PDF Chat Statistical analysis and handling of missing data in cluster randomized trials: a systematic review 2016 Mallorie H. Fiero
Shuang Huang
Eyal Oren
Melanie L. Bell
2
+ PDF Chat Treatment of Death in the Analysis of Longitudinal Studies of Gerontological Outcomes 2010 Terrence E. Murphy
Lanlan Han
Heather Allore
Peter Peduzzi
Thomas M. Gill
Haiqun Lin
2
+ Bayesian Approaches to Clinical Trials and Health‐Care Evaluation 2003 David J. Spiegelhalter
Keith R. Abrams
Jonathan P. Myles
2
+ Estimating causal effects of treatments in randomized and nonrandomized studies. 1974 Donald B. Rubin
2
+ Sample Size Calculations for Randomized Controlled Trials 2002 Janet Wittes
2
+ Multi-state models for event history analysis 2002 Per Kragh Andersen
Niels Keiding
2
+ PDF Chat Sample size and robust marginal methods for cluster‐randomized trials with censored event times 2014 Yujie Zhong
Richard J. Cook
2
+ Some Practical Guidelines for Effective Sample Size Determination 2001 Russell V. Lenth
2
+ EDF Statistics for Goodness of Fit and Some Comparisons 1974 Michael A. Stephens
2
+ Covariate-based constrained randomization of group-randomized trials 2004 Lawrence H. Moulton
2
+ Permutation tests for comparing marginal survival functions with clustered failure time data 2000 Jianwen Cai
Yu Shen
2
+ Exact, conditional, and predictive power in planning clinical trials 1989 Mohamed Moussa
2
+ Tutorial in biostatistics: competing risks and multi‐state models 2006 Hein Putter
Marta Fiocco
Ronald B. Geskus
2
+ Some thoughts on sample size: A Bayesian-frequentist hybrid approach 2012 KK Gordan Lan
Janet Wittes
2
+ Sample size and the probability of a successful trial 2006 Christy Chuang‐Stein
2
+ Competing risks regression for clustered data 2011 Bo Zhou
Jason P. Fine
Aurélien Latouche
Myriam Labopin
2
+ A Linear Models Approach to the Analysis of Survival and Extent of Disease in Multidimensional Contingency Tables 1972 Gary G. Koch
William D. Johnson
H. Dennis Tolley
2
+ Assurance in clinical trial design 2005 Anthony O’Hagan
John Stevens
Michael J. Campbell
2
+ PDF Chat Generating survival times to simulate Cox proportional hazards models 2005 Ralf Bender
Thomas Augustin
Maria Blettner
2
+ Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates 1995 Peter Peduzzi
John Concato
Alvan R. Feinstein
Theodore R. Holford
2
+ Projection from previous studies: A Bayesian and frequentist compromise 1987 Barry W. Brown
Jay Herson
E. Neely Atkinson
M. Elizabeth Rozell
2
+ PDF Chat Shared Frailty Models for Recurrent Events and a Terminal Event 2004 Lei Liu
Robert A. Wolfe
Xuelin Huang
2
+ Quantifying and documenting prior beliefs in clinical trials 2001 Kathryn Chaloner
Frank S. Rhame
2
+ Bayesian Approaches to Randomized Trials 1994 David J. Spiegelhalter
Laurence S. Freedman
Mahesh Parmar
2
+ Analysis of Multivariate Survival Data 2000 Philip Hougaard
2
+ Sample size calculation for complex clinical trials with survival endpoints 1995 Joanna H. Shih
2
+ Intent-to-treat analysis and the problem of crossovers 1991 Peter Peduzzi
Katherine M. Detre
Janet Wittes
Theodore Holford
2
+ Introduction to sample size determination and power analysis for clinical trials 1981 John M. Lachin
2
+ A computer program for transition life tables 1981 Cynthia Ziemba
Dorothea Collins
Peter Peduzzi
Katherine M. Detre
2
+ A two‐stage trial design for testing treatment, self‐selection and treatment preference effects 1989 Gerta RĂŒcker
2
+ Sample Size and Power When Designing a Randomized Trial for the Estimation of Treatment, Selection, and Preference Effects 2014 Robin Turner
Stephen D. Walter
Petra Macaskill
Kirsten McCaffery
Les Irwig
2
+ Optimal allocation of participants for the estimation of selection, preference and treatment effects in the two‐stage randomised trial design 2012 Stephen D. Walter
Robin Turner
Petra Macaskill
Kirsten McCaffery
Les Irwig
2
+ The Analysis of Failure Times in the Presence of Competing Risks 1978 Ross L. Prentice
John D. Kalbfleisch
Arthur V. Peterson
Nancy Flournoy
Vernon T. Farewell
N. E. Breslow
2
+ Applying Bayesian ideas in drug development and clinical trials 1993 David J. Spiegelhalter
Laurence S. Freedman
Mahesh Parmar
2
+ A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion 1986 David J. Spiegelhalter
Laurence S. Freedman
2
+ Statistical Considerations in the Intent-to-Treat Principle 2000 John M. Lachin
2
+ Type I error rate of the chi-square test in independence in R × C tables that have small expected frequencies. 1979 Drake R. Bradley
T. D. Bradley
Steven G. McGrath
Steven D. Cutcomb
2
+ A Proportional Hazards Model for the Subdistribution of a Competing Risk 1999 Jason P. Fine
Malcolm H. Ray
2
+ The Risk of Determining Risk with Multivariable Models 1993 John Concato
2
+ PDF Chat Frailty Models in Survival Analysis 2010 Andreas Wienke
2
+ Group sequential methods in the design and analysis of clinical trials 1977 Stuart J. Pocock
2
+ PDF Chat Causal Inference in Hybrid Intervention Trials Involving Treatment Choice 2008 Qi Long
Roderick J. A. Little
Xihong Lin
2
+ The EM Algorithm and Extensions 1998 Debashis Kushary
Geoffrey J. McLachlan
Thriyambakam Krishnan
2